CN Mobile Logo

Search form


Oncology and Hematology News and Journal Articles

Myeloproliferative Neoplasms: Translating New Discoveries Into Better Outcomes, Better Quality of Life

By Leslie Padrnos and Ruben A. Mesa
In this review, we demonstrate the evolving landscape of clinical investigation as researchers and clinicians attempt to address the important therapeutic needs of patients with myeloproliferative neoplasms.

Recent Content

A 67-year-old man presents with a mass in his right thigh, and a biopsy is performed. What is your diagnosis?

A phase III trial failed to demonstrate superiority of eribulin over treatment of physician’s choice in patients with heavily pretreated non–small-cell lung cancer.

A lower dose of rabbit anti–T-lymphocyte globulin was superior to a higher dose in children with hematologic malignancies undergoing transplant from an unrelated donor.

A 60-year-old woman presents with an ovarian tumor, and a biopsy is obtained. What is your diagnosis?

Adherence to screening protocols at cancer centers resulted in fewer emergency department visits and hospitalizations in the 2-month period after the screening.

The FDA Oncologic Drugs Advisory Committee has unanimously voted to recommend approval of the trastuzumab biosimilar MYL-1401O for the treatment of HER2-positive breast cancer.

Patients with metastatic renal cell carcinoma had durable responses and manageable safety when treated with the combination of nivolumab and ipilimumab.

By clicking Accept, you agree to become a member of the UBM Medica Community.